 | • レポートコード：QYR9ST02714 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のタイサブリ薬市場について調査・分析し、以下の構成でお届け致します。タイサブリ薬の種類別には、多発性硬化症、クローン病に、用途別には、病院、ドラッグストアに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別タイサブリ薬売上データ ・地域別タイサブリ薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別タイサブリ薬市場規模：多発性硬化症、クローン病 ・用途別タイサブリ薬市場規模：病院、ドラッグストア ・主要メーカーの企業情報：Biogen ・タイサブリ薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn’s disease in adults. Tysabri is usually given after other Crohn’s disease medications have been tried without successful treatment of this condition.The global Tysabri Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Tysabri Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Tysabri Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Tysabri Drugs in these regions.
This research report categorizes the global Tysabri Drugs market by top players/brands, region, type and end user. This report also studies the global Tysabri Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Biogen
Market size by Product
Multiple Sclerosis
Crohn’s Disease
Market size by End User
Hospital
Drugs Stores
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Tysabri Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Tysabri Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Tysabri Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Tysabri Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Tysabri Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Tysabri Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Tysabri Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Tysabri Drugs Market Size Growth Rate by Product
1.4.2 Multiple Sclerosis
1.4.3 Crohn’s Disease
1.5 Market by End User
1.5.1 Global Tysabri Drugs Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Drugs Stores
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Tysabri Drugs Market Size
2.1.1 Global Tysabri Drugs Revenue 2014-2025
2.1.2 Global Tysabri Drugs Sales 2014-2025
2.2 Tysabri Drugs Growth Rate by Regions
2.2.1 Global Tysabri Drugs Sales by Regions
2.2.2 Global Tysabri Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Tysabri Drugs Sales by Manufacturers
3.1.1 Tysabri Drugs Sales by Manufacturers
3.1.2 Tysabri Drugs Sales Market Share by Manufacturers
3.1.3 Global Tysabri Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Tysabri Drugs Revenue by Manufacturers
3.2.1 Tysabri Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Tysabri Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Tysabri Drugs Price by Manufacturers
3.4 Tysabri Drugs Manufacturing Base Distribution, Product Types
3.4.1 Tysabri Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Tysabri Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Tysabri Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Tysabri Drugs Sales by Product
4.2 Global Tysabri Drugs Revenue by Product
4.3 Tysabri Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Tysabri Drugs Breakdown Data by End User
6 North America
6.1 North America Tysabri Drugs by Countries
6.1.1 North America Tysabri Drugs Sales by Countries
6.1.2 North America Tysabri Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Tysabri Drugs by Product
6.3 North America Tysabri Drugs by End User
7 Europe
7.1 Europe Tysabri Drugs by Countries
7.1.1 Europe Tysabri Drugs Sales by Countries
7.1.2 Europe Tysabri Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Tysabri Drugs by Product
7.3 Europe Tysabri Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Tysabri Drugs by Countries
8.1.1 Asia Pacific Tysabri Drugs Sales by Countries
8.1.2 Asia Pacific Tysabri Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Tysabri Drugs by Product
8.3 Asia Pacific Tysabri Drugs by End User
9 Central & South America
9.1 Central & South America Tysabri Drugs by Countries
9.1.1 Central & South America Tysabri Drugs Sales by Countries
9.1.2 Central & South America Tysabri Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Tysabri Drugs by Product
9.3 Central & South America Tysabri Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Tysabri Drugs by Countries
10.1.1 Middle East and Africa Tysabri Drugs Sales by Countries
10.1.2 Middle East and Africa Tysabri Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Tysabri Drugs by Product
10.3 Middle East and Africa Tysabri Drugs by End User
11 Company Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Company Business Overview
11.1.3 Biogen Tysabri Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Biogen Tysabri Drugs Products Offered
11.1.5 Biogen Recent Development
12 Future Forecast
12.1 Tysabri Drugs Market Forecast by Regions
12.1.1 Global Tysabri Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Tysabri Drugs Revenue Forecast by Regions 2019-2025
12.2 Tysabri Drugs Market Forecast by Product
12.2.1 Global Tysabri Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Tysabri Drugs Revenue Forecast by Product 2019-2025
12.3 Tysabri Drugs Market Forecast by End User
12.4 North America Tysabri Drugs Forecast
12.5 Europe Tysabri Drugs Forecast
12.6 Asia Pacific Tysabri Drugs Forecast
12.7 Central & South America Tysabri Drugs Forecast
12.8 Middle East and Africa Tysabri Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Tysabri Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Tysabri Drugs Product Picture
Table Tysabri Drugs Market Segments
Table Key Manufacturers Tysabri Drugs Covered
Table Global Tysabri Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Tysabri Drugs Sales Market Share by Product 2014-2025
Figure Multiple Sclerosis Product Picture
Table Major Manufacturers of Multiple Sclerosis
Figure Crohn's Disease Product Picture
Table Major Manufacturers of Crohn's Disease
Table Global Tysabri Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospital
Figure Drugs Stores
Figure Tysabri Drugs Report Years Considered
Figure Global Tysabri Drugs Market Size 2014-2025 (Million US$)
Figure Global Tysabri Drugs Sales 2014-2025 (K Units)
Table Global Tysabri Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Tysabri Drugs Sales by Regions 2014-2019 (K Units)
Table Global Tysabri Drugs Sales Market Share by Regions 2014-2019
Figure Global Tysabri Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Tysabri Drugs Sales Market Share by Regions
Table Global Tysabri Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Tysabri Drugs Revenue Market Share by Regions 2014-2019
Figure Global Tysabri Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Tysabri Drugs Revenue Market Share by Regions
Table Global Tysabri Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Tysabri Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Tysabri Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Tysabri Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Tysabri Drugs Revenue Share by Manufacturers (2014-2019)
Figure Tysabri Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Tysabri Drugs Price (2014-2019) (USD/Unit)
Table Tysabri Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Tysabri Drugs Product Type
Table Date of International Manufacturers Enter into Tysabri Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Tysabri Drugs Sales by Product (2014-2019) (K Units)
Table Global Tysabri Drugs Sales Share by Product (2014-2019)
Figure Global Tysabri Drugs Sales Market Share by Product (2014-2019)
Figure Global Tysabri Drugs Sales Market Share by Product in 2018
Table Global Tysabri Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Tysabri Drugs Revenue Share by Product (2014-2019)
Figure Global Tysabri Drugs Revenue Market Share by Product (2014-2019)
Figure Global Tysabri Drugs Revenue Market Share by Product in 2018
Table Tysabri Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Tysabri Drugs Sales by End User (2014-2019) (K Units)
Table Global Tysabri Drugs Sales Share by End User (2014-2019)
Figure Global Sales Tysabri Drugs Market Share by End User (2014-2019)
Figure Global Sales Tysabri Drugs Market Share by End User in 2018
Figure North America Tysabri Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Tysabri Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Tysabri Drugs Sales by Countries (2014-2019) (K Units)
Table North America Tysabri Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Tysabri Drugs Sales Market Share by Countries
Table North America Tysabri Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Tysabri Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Tysabri Drugs Revenue Market Share by Countries
Figure United States Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Tysabri Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Tysabri Drugs Sales by Product (2014-2019) (K Units)
Table North America Tysabri Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Tysabri Drugs Market Share by Product
Table North America Tysabri Drugs Sales by End User (2014-2019) (K Units)
Table North America Tysabri Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Tysabri Drugs Market Share by End User
Figure Europe Tysabri Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Tysabri Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Tysabri Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Tysabri Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Tysabri Drugs Sales Market Share by Countries
Table Europe Tysabri Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Tysabri Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Tysabri Drugs Revenue Market Share by Countries
Figure Germany Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Tysabri Drugs Sales by Product (2014-2019) (K Units)
Table Europe Tysabri Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Tysabri Drugs Market Share by Product
Table Europe Tysabri Drugs Sales by End User (2014-2019) (K Units)
Table Europe Tysabri Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Tysabri Drugs Market Share by End User
Figure Asia Pacific Tysabri Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Tysabri Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Tysabri Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Tysabri Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Tysabri Drugs Sales Market Share by Countries
Table Asia Pacific Tysabri Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Tysabri Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Tysabri Drugs Revenue Market Share by Countries
Figure China Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Tysabri Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Tysabri Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Tysabri Drugs Market Share by Product
Table Asia Pacific Tysabri Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Tysabri Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Tysabri Drugs Market Share by End User
Figure Central & South America Tysabri Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Tysabri Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Tysabri Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Tysabri Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Tysabri Drugs Sales Market Share by Countries
Table Central & South America Tysabri Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Tysabri Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Tysabri Drugs Revenue Market Share by Countries
Figure Brazil Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Tysabri Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Tysabri Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Tysabri Drugs Market Share by Product
Table Central & South America Tysabri Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Tysabri Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Tysabri Drugs Market Share by End User
Figure Middle East and Africa Tysabri Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Tysabri Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Tysabri Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Tysabri Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Tysabri Drugs Sales Market Share by Countries
Table Middle East and Africa Tysabri Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Tysabri Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Tysabri Drugs Revenue Market Share by Countries
Figure GCC Countries Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Tysabri Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Tysabri Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Tysabri Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Tysabri Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Tysabri Drugs Market Share by Product
Table Middle East and Africa Tysabri Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Tysabri Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Tysabri Drugs Market Share by End User
Table Biogen Company Details
Table Biogen Tysabri Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Recent Development
Table Global Tysabri Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Tysabri Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Tysabri Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Tysabri Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Tysabri Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Tysabri Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Tysabri Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Tysabri Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Tysabri Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Tysabri Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Tysabri Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Tysabri Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Tysabri Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Tysabri Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Tysabri Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Tysabri Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Tysabri Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Tysabri Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Tysabri Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Tysabri Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Tysabri Drugs Value Chain
Table Tysabri Drugs Customers List
Table Tysabri Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
多発性硬化症薬の世界市場：市場規模・現状・予測 Multiple sclerosis (MS) is a nervous system disease which affects spinal cord and the brain. MS damages the myelin sheath. Myelin sheath is a term which exemplifies that material which surrounds and protects human nerve cells. This damage blocks messages between brain and the body and leads to the s…- 虚血性心疾患（IHD）医薬品の世界市場：インサイト・予測 Ischemic heart disease (IHD), refers to a group of diseases which includes stable angina, unstable angina, myocardial infarction, and sudden cardiac death. It is within the group of cardiovascular diseases of which it is the most common type. A common symptom is chest pain or discomfort which may tr…
- 炎症性腸疾患薬の世界市場：インサイト・予測 Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease. The growth in prevalence of inflammatory bowel diseases such as ulcerative …
- 泌尿生殖器薬の世界市場：インサイト・予測 A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases.The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pi…
- 細菌性膣炎薬の世界市場：インサイト・予測 Bacterial vaginosis is an imbalance of "good" and "bad" bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis inclu…